Could a common antidepressant help people battling pancreatic cancer?
NCT ID NCT05289830
Summary
This study tested if the antidepressant escitalopram could prevent depression and improve quality of life in people with localized pancreatic or related cancers. Participants were receiving chemotherapy before possible surgery and were not already on psychiatric medications. The trial was terminated early after enrolling only 4 people, so no clear results are available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
Conditions
Explore the condition pages connected to this study.